Camurus AB (CAMX) NPV

Sell:532.50 SEKBuy:534.00 SEKPrice increased18.50 SEK (3.59%)

Prices delayed by at least 15 minutes
Sell:532.50 SEK
Buy:534.00 SEK
Change:Price increased18.50 SEK (3.59%)
Deal now
Prices delayed by at least 15 minutes
Sell:532.50 SEK
Buy:534.00 SEK
Change:Price increased18.50 SEK (3.59%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open520.00 SEK
Previous close515.00 SEK
Market capSEK 30.89bn
P/E ratio41.47
Volume103,201
Dividend yield0.00%
EMS-

Company information

Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue59.88m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 4.74bn
Total liabilitiesSEK 504.56m
Net debt-SEK 3.62bn

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.